Question

Difficulty: MediumBipolar and Related Disorders

Accompanied by her husband, a 31-year-old architect presents to her primary care physician with complaints of overwhelming fatigue and persistent low mood that began a month ago. She reports spending most of her days in bed, missing work deadlines, and feeling intensely guilty about her lack of productivity. She states, "I just don't see the point in trying anymore." Upon further questioning, her husband recalls an unusual period two years prior. Over a span of 15 days, the patient barely slept, talked continuously about redesigning their entire city, and impulsively purchased $15,000 worth of construction materials. That episode led to severe financial distress and a brief psychiatric hospitalization, after which she returned to her baseline. Laboratory studies show a thyroid-stimulating hormone (TSH) level of 1.1 mU/L (normal: 0.5–5.0 mU/L) and a free T4 level of 0.9 ng/dL (normal: 0.9–1.7 ng/dL). She currently takes no medications. Which of the following is the most appropriate pharmacotherapy to initiate for this patient?

  1. A
    Levothyroxine
  2. B
    Long-acting injectable risperidone
  3. QuetiapineAnswer
  4. D
    Sertraline
  5. E
    Venlafaxine

Answer

The most appropriate pharmacotherapy is quetiapine.
The patient's presentation of overwhelming fatigue, persistent low mood, and intense guilt represents a major depressive episode. However, her clear history of a 15-day manic episode (decreased need for sleep, pressured speech, grandiosity, and severe impairment requiring hospitalization) establishes the diagnosis of bipolar I disorder. The first-line treatment for acute bipolar depression includes specific second-generation antipsychotics (e.g., quetiapine, lurasidone, cariprazine) or mood stabilizers (e.g., lithium, lamotrigine). Quetiapine is an FDA-approved monotherapy for acute bipolar depression that effectively targets mood symptoms without the risk of inducing a manic switch.

Step-by-Step Solution

1
Analyze the patient's current symptoms and past psychiatric history.
Current symptoms indicate a major depressive episode (fatigue, low mood, guilt, anhedonia). The past history of decreased sleep, grandiosity, impulsivity, and hospitalization lasting 15 days indicates a prior manic episode.
Establishing the overarching diagnosis is required to determine the correct pharmacologic treatment algorithm.
2
Synthesize the findings to make a definitive diagnosis.
The combination of at least one lifetime manic episode and a current depressive episode confirms the diagnosis of Bipolar I disorder, current episode depressed.
Differentiating bipolar depression from unipolar major depressive disorder is critical, as the treatments differ significantly and unipolar treatments can be dangerous in bipolar disorder.
3
Select the most appropriate pharmacotherapy for acute bipolar depression.
Quetiapine is selected over antidepressant monotherapy or thyroid replacement.
Quetiapine is an FDA-approved monotherapy for bipolar depression that treats mood symptoms without risking a manic switch. Labs rule out hypothyroidism, and the symptom timeline rules out a primary psychotic disorder.

Key Concept

The diagnosis of bipolar I disorder is established by the presence of at least one lifetime manic episode. Acute bipolar depression must be treated with specific atypical antipsychotics (e.g., quetiapine, lurasidone) or mood stabilizers, rather than antidepressant monotherapy, to avoid precipitating a manic switch.
Estimated Time:1m 30s
Rate this question